Overview
RGCD (Recombinant Granulocyte Colony-Stimulating Factor) is a biotechnology-derived version of the natural G-CSF protein, produced using genetically modified E. coli or mammalian cells. It plays a critical role in hematopoiesis by promoting the proliferation and differentiation of neutrophil precursors. The development of RGCD revolutionized supportive care in oncology, significantly reducing infection risks during chemotherapy. Its recombinant form ensures consistent quality and avoids the contamination risks associated with earlier blood-derived products.
Physical and Chemical Properties
As a glycoprotein, RGCD exhibits complex tertiary structure essential for biological activity. The lyophilized form maintains stability for 24-36 months when properly stored, while liquid formulations typically have shorter shelf lives. Its isoelectric point ranges between 5.5-6.5, and the molecule contains multiple disulfide bonds critical for receptor binding. Analytical methods like HPLC and mass spectrometry are used for quality control to ensure proper folding and absence of aggregates.
Main Applications
In clinical practice, RGCD is primarily administered to prevent febrile neutropenia in cancer patients receiving myelosuppressive chemotherapy. It's also used to mobilize hematopoietic stem cells for collection prior to transplantation. Off-label uses include treating neonatal neutropenia and certain HIV-related conditions. The dosing regimen varies from daily injections to single-dose protocols depending on the indication and patient characteristics.
Safety and Storage
Proper cold chain maintenance is crucial - exposure to temperatures above 25°C for extended periods can denature the protein. Frozen storage is acceptable but repeated freeze-thaw cycles should be avoided. Healthcare workers should follow biosafety protocols when handling, as improper administration may cause serious adverse events including capillary leak syndrome. Patient monitoring for splenomegaly and allergic reactions is recommended during treatment courses.
B2B Procurement Guide
Pharmaceutical buyers should verify suppliers' GMP compliance and batch testing documentation. Key procurement considerations include: minimum order quantities (often case-dependent), lead times (typically 4-8 weeks for international shipments), and temperature-controlled packaging specifications. For institutional purchasers, contract terms often include performance-based rebates and volume discounts. Customs clearance requires special attention to biological product regulations which vary by country.